• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ASXL1/2 介导的 BAP1 去泛素化酶别构调节的动力学特征。

Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.

机构信息

The Wistar Institute, Philadelphia, Pennsylvania.

Department of Biochemistry and Molecular Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Mol Cancer Res. 2021 Jul;19(7):1099-1112. doi: 10.1158/1541-7786.MCR-20-0080. Epub 2021 Mar 17.

DOI:10.1158/1541-7786.MCR-20-0080
PMID:33731362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8254751/
Abstract

BAP1 is an ubiquitin hydrolase whose deubiquitinase activity is mediated by polycomb group-like protein ASXL2. Cancer-related mutations/deletions lead to loss-of-function by targeting the catalytic ubiquitin C-terminal hydrolase (UCH) or UCH37-like domain (ULD) domains of BAP1, and the latter disrupts binding to ASXL2, an obligate partner for BAP1 enzymatic activity. However, the biochemical and biophysical properties of domains involved in forming the enzymatically active complex are unknown. Here, we report the molecular dynamics, kinetics, and stoichiometry of these interactions. We demonstrate that interactions between BAP1 and ASXL2 are direct, specific, and stable to biochemical and biophysical manipulations as detected by isothermal titration calorimetry (ITC), GST association, and optical biosensor assays. Association of the ASXL2-AB box greatly stimulates BAP1 activity. A stable ternary complex is formed, comprised of the BAP1-UCH, BAP1-ULD, and ASXL2-AB domains. Stoichiometric analysis revealed that one molecule of the ULD domain directly interacts with one molecule of the AB box. Real-time kinetic analysis of the ULD/AB protein complex to the BAP1-UCH domain, based on surface plasmon resonance, indicated that formation of the ULD/AB complex with the UCH domain is a single-step event with fast association and slow dissociation rates. experiments validated in cells that the ASXL-AB box directly regulates BAP1 activity. IMPLICATIONS: Collectively, these data elucidate molecular interactions between specific protein domains regulating BAP1 deubiquitinase activity, thus establishing a foundation for small-molecule approaches to reactivate latent wild-type BAP1 catalytic activity in -mutant cancers.

摘要

BAP1 是一种泛素水解酶,其去泛素酶活性由多梳组样蛋白 ASXL2 介导。癌症相关的突变/缺失通过靶向 BAP1 的催化泛素 C 端水解酶 (UCH) 或 UCH37 样结构域 (ULD) 结构域导致功能丧失,后者破坏了与 ASXL2 的结合,ASXL2 是 BAP1 酶活性的必需伴侣。然而,参与形成具有酶活性的复合物的结构域的生化和生物物理特性尚不清楚。在这里,我们报告了这些相互作用的分子动力学、动力学和化学计量学。我们证明了 BAP1 和 ASXL2 之间的相互作用是直接的、特异性的,并且通过等温滴定量热法 (ITC)、GST 关联和光学生物传感器测定来检测到的生化和生物物理操作是稳定的。ASXL2-AB 盒的结合极大地刺激了 BAP1 的活性。形成了一个稳定的三元复合物,由 BAP1-UCH、BAP1-ULD 和 ASXL2-AB 结构域组成。化学计量分析表明,一个 ULD 结构域分子直接与一个 AB 盒分子相互作用。基于表面等离子体共振的实时动力学分析表明,ULD/AB 蛋白复合物与 BAP1-UCH 结构域的形成是一个单步事件,具有快速的缔合和缓慢的解离速率。细胞实验验证了 ASXL-AB 盒直接调节 BAP1 活性。意义:总的来说,这些数据阐明了调节 BAP1 去泛素酶活性的特定蛋白质结构域之间的分子相互作用,从而为重新激活 - 突变癌症中潜在的野生型 BAP1 催化活性的小分子方法奠定了基础。

相似文献

1
Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.ASXL1/2 介导的 BAP1 去泛素化酶别构调节的动力学特征。
Mol Cancer Res. 2021 Jul;19(7):1099-1112. doi: 10.1158/1541-7786.MCR-20-0080. Epub 2021 Mar 17.
2
Familial and Somatic Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains.家族性和体细胞突变使 ASXL1/2 介导的 BAP1 去泛素化酶的变构调节失活,靶向多个独立结构域。
Cancer Res. 2018 Mar 1;78(5):1200-1213. doi: 10.1158/0008-5472.CAN-17-2876. Epub 2017 Dec 28.
3
The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.BAP1/ASXL2组蛋白H2A去泛素化酶复合物调控细胞增殖并在癌症中失调。
J Biol Chem. 2015 Nov 27;290(48):28643-63. doi: 10.1074/jbc.M115.661553. Epub 2015 Sep 28.
4
Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1.癌症相关突变对BAP1结构-活性关系的影响
J Mol Biol. 2022 May 15;434(9):167553. doi: 10.1016/j.jmb.2022.167553. Epub 2022 Mar 19.
5
Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.肿瘤来源的 ASXL1 新形成突变会损害 BAP1-ASXL1-FOXK1/K2 转录网络。
Protein Cell. 2021 Jul;12(7):557-577. doi: 10.1007/s13238-020-00754-2. Epub 2020 Jul 18.
6
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.ASXLs 的单泛素化控制肿瘤抑制因子 BAP1 的去泛素化酶活性。
Nat Commun. 2018 Oct 22;9(1):4385. doi: 10.1038/s41467-018-06854-2.
7
A common ancestry for BAP1 and Uch37 regulators.BAP1 和 Uch37 调节因子的共同祖先。
Bioinformatics. 2012 Aug 1;28(15):1953-6. doi: 10.1093/bioinformatics/bts319. Epub 2012 May 29.
8
BAP1/ASXL1 recruitment and activation for H2A deubiquitination.BAP1/ASXL1 募集与激活以进行H2A去泛素化
Nat Commun. 2016 Jan 7;7:10292. doi: 10.1038/ncomms10292.
9
Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.撤回声明:组蛋白 H2B 泛素化通过 ASXL1 和 BAP1 的合作调节视黄酸信号通路。
Mol Cell. 2013 Jul 25;51(2):200-10. doi: 10.1016/j.molcel.2013.06.005. Epub 2013 Jul 11.
10
Oxidation of catalytic cysteine of human deubiquitinase BAP1 triggers misfolding and aggregation in addition to functional loss.人类去泛素化酶BAP1的催化半胱氨酸氧化除了导致功能丧失外,还会引发错误折叠和聚集。
Biochem Biophys Res Commun. 2022 Apr 9;599:57-62. doi: 10.1016/j.bbrc.2022.02.029. Epub 2022 Feb 10.

引用本文的文献

1
BAP1 Loss Affords Lipotoxicity Resistance in Uveal Melanoma.BAP1缺失赋予葡萄膜黑色素瘤抗脂毒性能力。
Pigment Cell Melanoma Res. 2025 May;38(3):e70021. doi: 10.1111/pcmr.70021.
2
Identification of a de novo variant in the ASXL2 gene related to Shashi-Pena syndrome.鉴定出一个与 Shashi-Pena 综合征相关的 ASXL2 基因中的新生变异。
Mol Genet Genomic Med. 2023 Nov;11(11):e2251. doi: 10.1002/mgg3.2251. Epub 2023 Jul 26.

本文引用的文献

1
Structural Basis for the Activation of the Deubiquitinase Calypso by the Polycomb Protein ASX.多梳蛋白 ASX 激活去泛素化酶 Calypso 的结构基础。
Structure. 2019 Mar 5;27(3):528-536.e4. doi: 10.1016/j.str.2018.11.013. Epub 2019 Jan 10.
2
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.ASXLs 的单泛素化控制肿瘤抑制因子 BAP1 的去泛素化酶活性。
Nat Commun. 2018 Oct 22;9(1):4385. doi: 10.1038/s41467-018-06854-2.
3
Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris.单细胞转录组学分析 20 种小鼠器官构建小鼠多器官单细胞图谱。
Nature. 2018 Oct;562(7727):367-372. doi: 10.1038/s41586-018-0590-4. Epub 2018 Oct 3.
4
A bidentate Polycomb Repressive-Deubiquitinase complex is required for efficient activity on nucleosomes.双齿 Polycomb 抑制-去泛素化酶复合物是在核小体上有效发挥活性所必需的。
Nat Commun. 2018 Sep 26;9(1):3932. doi: 10.1038/s41467-018-06186-1.
5
Familial and Somatic Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains.家族性和体细胞突变使 ASXL1/2 介导的 BAP1 去泛素化酶的变构调节失活,靶向多个独立结构域。
Cancer Res. 2018 Mar 1;78(5):1200-1213. doi: 10.1158/0008-5472.CAN-17-2876. Epub 2017 Dec 28.
6
Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2.鉴定谷氨酸转运体 EAAT2 的新型别构调节剂。
ACS Chem Neurosci. 2018 Mar 21;9(3):522-534. doi: 10.1021/acschemneuro.7b00308. Epub 2017 Nov 30.
7
Cardiovascular Risk Factors and Carotid Intima-Media Thickness in a Colombian Population With Psoriasis.哥伦比亚银屑病患者的心血管危险因素与颈动脉内膜中层厚度
Actas Dermosifiliogr. 2017 Oct;108(8):738-745. doi: 10.1016/j.ad.2017.04.015. Epub 2017 Jun 27.
8
Molecular modeling in the age of clinical genomics, the enterprise of the next generation.临床基因组学时代的分子建模,下一代的企业。
J Mol Model. 2017 Mar;23(3):75. doi: 10.1007/s00894-017-3258-3. Epub 2017 Feb 15.
9
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.Bap1是一种真正的肿瘤抑制因子:来自携带杂合性生殖系Bap1突变的小鼠模型的遗传学证据。
Cancer Res. 2016 May 1;76(9):2836-44. doi: 10.1158/0008-5472.CAN-15-3371. Epub 2016 Feb 19.
10
An evolutionarily conserved DNA architecture determines target specificity of the TWIST family bHLH transcription factors.一种进化上保守的DNA结构决定了TWIST家族bHLH转录因子的靶标特异性。
Genes Dev. 2015 Mar 15;29(6):603-16. doi: 10.1101/gad.242842.114. Epub 2015 Mar 11.